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Abstract
Background This prospective randomised study evaluated
whether non-knitted and non-woven lightweight implants
can inXuence postoperative pain and time of return to
normal activity, without increasing the recurrence rate in
Lichtenstein inguinal hernioplasty.
Methods Patients were operated on in four centres, ran-
domised blindly into two groups with respect to the mesh
used: Surgimesh WN (non-woven polypropylene microW-
bre sheet) and heavy weight polypropylene mesh. The oper-
ation was performed according to the Lichtenstein
technique. Follow-up was designed for 7 days, and 3, 6, 12
and 60 months. The objectives were to assess the incidence
of early and late complications, recurrence rate, and postop-
erative pain.
Results A total of 220 patients were randomised; after
monitoring visits (exclusion of one hospital), 202 qualiWed
for the assessment. At 60 months, the recurrence rate did
not diVer statistically. Less pain on the 7th postoperative
day, and at 3 months, was observed in the WN group. No
other diVerences were observed.
Conclusions Use of a lightweight non-woven polypropyl-
ene implant is a valuable alternative to the use of knitted or
woven meshes in the Lichtenstein method. Postoperative
pain and recurrence were reduced at short term follow-up,
but no statistical diVerence in recurrence rate was observed at
12 and 60 month follow-up in the patient population tested.
Keywords Inguinal hernia · Lichtenstein · 
Surgimesh WN · Lightweight mesh
Introduction
In the twenty-Wrst century, mesh implantation has become
standard in inguinal hernioplasty. Although many diVerent
procedures and mesh types and shapes have been created,
the Lichtenstein technique is still the most popular, produc-
ing identical results in many surgical centres [1]. The recur-
rence rate after repair using this technique varies from <1%
in specialists’ hands to 3% in regional hospitals; however,
chronic pain, which has been reported by >20% of patients,
has become the main postoperative problem associated
with this surgery [2, 3]. Experimental studies have hypothe-
sised that the inXammatory reaction and scar tissue forma-
tion caused by the mesh is responsible for the high
incidence of postoperative pain [4]. Material-reduced
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meshes can decrease this inXammation and inXuence the
intensity and rate of pain. Clinical studies on composite
(partially absorbable) meshes published in recent years
have conWrmed this hypothesis [5–9]. All of the materials
examined (Vypro, Vypro II, Ultrapro) were used to make
macroporous, knitted, partially absorbable meshes of high
elasticity. Because of these properties, increased recurrence
was noted in one study, but all of the authors were con-
vinced that a dedicated technique for implantation could be
designed that would avoid this complication [7]. Further-
more, the role of weight reduction and/or the mesh’s mac-
roporous property was not documented as a reason for the
decreased rate of pain.
Recently, other materials of reduced weight have been
created. The WN mesh that we describe is a low-weight
mesh, not knitted or woven, that was designed as a highly
porous polypropylene sheet. Until now, this material has
not been assessed in randomised trials. Because of its
unique design, it allows us to characterise the inXuence of
polypropylene weight reduction on recurrence and pain in
the postoperative period.
Patients and methods
Patients aged between 20 and 75 years who were diagnosed
with primary inguinal hernia were eligible to participate in
the study. Patients with a history of inguinal hernia repaired
with a synthetic mesh, or those on chronic immunosuppres-
sive or corticosteroid therapy, radio- or chemotherapy cur-
rently or in the past 3 months, as well as those with chronic
renal failure (on dialysis), clinically diagnosed hepatic fail-
ure or active bacterial endocarditis, proven mental illness,
thrombocytopenia (platelets <100 £ 109/l) or who were
pregnant were excluded from the study. The patients were
recruited and operated on in four hospitals in Poland. All
patients gave informed consent. The study was approved by
the Ethical Committee of the Medical University of Gdansk
for all participating centres, and registered in the Clinical
Trials Database of Medical University of Gdansk in accor-
dance with Polish law (approval and registration number:
NKEBN/872/3003).
Operative technique and anaesthesia
The standard operative technique by Lichtenstein and Amid
was used in both groups [2]. In the control group (called the
HW PP group), heavyweight polypropylene mesh was
implanted (PROLENE, Ethicon GMbH, Hamburg,
Germany). In the treated group (the WN group), a low-
weight (approximately 38 g/m2), non-woven, non-knitted
implant made from polypropylene microWbres was used
(Surgimesh WN®, Aspide Medical, France) (Fig. 1).
In both the WN and HW PP groups, Prolene 2-0 was
used for mesh implantation. Cefazolin (1 g) was adminis-
tered intravenously (IV) 0.5 h before the operation as anti-
biotic prophylaxis. Standardised anaesthesia was applied
for all patients. A subdural block was eVected with 4 ml
bupivacaine hydrochloride (Marcaine Spinal 0.5% Heavy,
Astra Zeneca Pharma) using a pencil point needle (27 G).
In addition, the amount of Xuid given in the postoperative
period was standardised (IV crystalloid: 2 ml kg¡1 h¡1
from the last drink taken until the end of the operation; after
the operation, a minimum of 1.5 l Xuid by mouth). Four
hours after the operation, patients were allowed to stand up;
after 6 h, they could be discharged.
Objectives and outcomes
We hypothesised that the WN mesh would cause less pain
at short- and long-term observations. In this trial, we stud-
ied patients at six controlled visits over 1 year (at hospital
stay and postoperatively at 7 days, 3 months, 6 months, and
1 and 5 years). Additionally, hernia characteristics, time
of occurrence, and preoperative pain were assessed. The
5-year observation was designed to assess long-term results
(recurrence rate and chronic pain). All visits were con-
ducted at each respective hospital. Physical examinations in
the postoperative period were performed by a surgeon who
had not been involved in the operation and who was
blinded to the type of mesh used. Postoperative pain and
quality of life questionnaires were administered by a nurse
or student who was also blinded to the type of mesh. The
primary endpoint of the study was presence of pain or her-
nia recurrence. Acute pain was deWned as pain reported by
a patient within the Wrst 6 months after the operation. Pain
after 12 months was deWned as “chronic”, following the
deWnition given by Kehlet et al. [9]. Recurrence was noted
based on a surgeon’s examination and diagnosis. Presence
Fig. 1 Surgimesh: a low-weight, non-woven, non-knitted implant
made from polypropylene microWbreHernia (2011) 15:495–501 497
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of pain and recurrence were assessed on every visit sched-
uled in the study Xow chart. Additionally, the following
data were collected during the hospital stay and until
3 months later: perioperative complications (haematoma,
seroma, nerve damage), urinary retention, need for urinary
catheter placement and wound infection rate.
Study Xow chart
Four hospitals were included in the trial according to their
capacity for patients and experience with the Lichtenstein
technique (a minimum of 150 inguinal hernias/year, and a
minimum of 200 Lichtenstein procedures done by the
investigator). Before patients were recruited, a workshop
on the operative technique for the investigational mesh was
conducted for all trial participants. A total of 220 patients
were randomised in the trial. The randomisation scheme
was generated using the website randomisation.com (http://
www.randomization.com), which utilises the pseudo-ran-
dom number generator of Wichmann and Hill, modiWed by
McLeod. Subjects were divided into groups of equal size,
which were distributed to each hospital prior to patient
inclusion. Three months after randomisation had ended,
monitoring visits in all centres were conducted by members
of the steering committee. The data were double-checked
by comparing patient study Wles versus hospital documen-
tation and against random patient personal reports (via
visits or telephone examination) (Fig. 2).
Statistical analysis
The minimum number of patients in each study group was
calculated based on the assumption that reduction of pain
incidence from 20% to 30% (as observed earlier in individu-
als with polypropylene mesh) to 10% in the Wrst 3 months of
observation would be clinically signiWcant. With this
assumption, a test power of 80%, and an alpha level of 0.05,
we calculated that 100 patients were needed in each study
group. The Wnal patient number was 110 per group due to
anticipation of possible patient “losses” (see “Study  Xow
chart”). This number of patients corresponded with the trials
(available at the time of study design) by Post or Kinsnorth
that were designed to assess new materials (lightweight
polypropylene) or devices (PHS, Mesh-Per-Wx-plug) [10].
Statistical calculations were performed using Statistica 7.1
PL (Polish version) software (StatSoft, Tulsa, OK). Descrip-
tive statistics were used to characterise patient groups, and
mean (standard deviation) or median values (range of val-
ues) were given, depending on the type of data and a normal
data distribution in the interval scale. Normal distributions
were veriWed with the W Shapiro–Wilk’s test. Data were
compared using Student’s t test or the Mann–Whitney
U test. Repeated measurements were analysed using a two-
way analysis of variance (ANOVA) test for repeated mea-
surements, with subsequent analysis of signiWcant diVer-
ences with the post-hoc method (HSD Tukey’s test) when
appropriate. Categorical data were presented as percentages
and 95% conWdence intervals and compared using a chi-
square test, with the Yates correction applied when neces-
sary. A signiWcance level of P < 0.05 was adopted.
Results
Of all the patients randomised after monitoring visits, 101
patients in the WN group and 99 in the HW PP group were
included in the trial database. Baseline data for both groups
are presented in Table 1. After randomisation, statistical
diVerences was noted between the groups according to her-
nia size (medium indirect hernias were often presented in
the WN group, smaller indirect in the HW PP group). From
these patients, 12-month follow-up examinations were
completed by 98.5% (3 patients were lost to follow-up),
respectively, and 5-year follow-up was completed by
90.1% (an additional 17 patients lost to follow-up).
The median operative time was 40 min (15–125 min) for
the WN group and 35 min (20–95 min) for the HW PP
group (P = 0.43). No serious perioperative or postoperative
complications were noted in either group, and there were
no statistically signiWcant diVerences between the groups,
except that wound redness (1% vs 8.1%; P = 0.013) and
superWcial haematoma (1% vs 7%; P = 0.07) were often
noted in the HW PP group (Table 2). Postoperative mea-
surements revealed a signiWcantly higher frequency of pain
in the HW PP group in early visits (7 days and 3 months)
(Table 3). However, although this diVerence was also noted
after 6 months and 1 year, it was not signiWcant due to the
small number of patients suVering from pain in both groups
(<10%), No diVerence was noted at the 5-year observation
point (Table 3). The intensity of pain measured in VAS
(data were counted for the whole group, not only for the
patients with pain) was also lower in the WN group,
although a statistical diVerence was found only 7 days post-
operatively (P = 0.0012). It should be mentioned that the
intensity of pain was slightly higher in the HWPP group
before surgery, but this diVerence was not statistically sig-
niWcant. In addition, pain after 7 days did not diVer from the
baseline for the HW PP group, as opposed to the WN
group, in which it was statistically lower (P = 0.0006). In
both groups, the intensity of pain measured for the whole
group was signiWcantly lower after 3 months compared to
baseline (all P values <0.05). Statistical analysis of the
intensity of pain (VAS) was not possible to calculate for the
whole population after 3 months due to the small number of
patients suVering from pain. Intensity of pain in the Wrst
3 months is presented in Fig. 3.498 Hernia (2011) 15:495–501
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The incidence of recurrence was slightly higher in the
HW PP group (3%) than in the WN group (1%) at 5 years,
but no statistical diVerence was found (P = 0.61). All recur-
rences were in male patients and occurred within the Wrst
2 years of follow-up. In all cases, the recurrence was found
above the pubic bone at the mesh margin.
Discussion
In this study, a newly introduced implant of a diVerent design
resulted in an improved pain proWle and lower recurrence rate
at 60-month follow-up, compared to rates for the knitted poly-
propylene traditionally used for Lichtenstein hernioplasty. We
have conWrmed that this mesh may be used in a routine clinical
setting as the Wrst-choice mesh for inguinal hernia repair. This
multicentre trial was created based on our previous Wndings
from a small pilot study that indicated the possible advantages
of this implant [11]. Previously, we encountered less pain with
WN versus heavyweight polypropylene mesh, and no recur-
rences in the WN mesh group. The group treated in that study
was quite small (25 patients in each cohort), so those diVer-
ences might have been coincidental. Based on those results, it
was mandatory to design and conduct a larger trial.
Fig. 2 Randomized trial of WN or polypropylene mesh in Lichtenstein primary inguinal hernia repair. + Included into Wnal analysis after moni-
toring visits in the hospitals, * excluded after monitoring visits in hospitals—see text
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In recent decades, many studies had proven that use of
mesh decreases acute pain (up to 6–12 months) compared
to tension methods. However, the incidence and intensity of
postoperative pain are still high, aVecting up to 20% of
patients operated on with mesh [12, 13]. To reduce this
problem, companies are searching for new materials that
can potentially reduce the number of patients suVering from
pain due to the presence of a foreign body after the proce-
dure. Experimental studies have shown that the extent of
reaction to a foreign body, with the scar tissue and inXam-
matory reaction it provokes, depends on the amount and
structure of the material implanted [4]. New meshes have
been introduced into the market. An absorbable component
Table 1 Patient baseline data
a Compared using Student’s t test
b Compared using U Mann–Whitney’s test
c Calculated with chi-square test
d Calculated with chi-square test with Yates correction
Non-woven WN,
(n = 100)
HW PP,
(n =9 9 )
P value
Age (years) 55.3 § 14.9 58.5 § 13.7 0.17a
Weight (kg) 76.8 § 10.5 75.8 § 11.0 0.56a
Height (cm) 174 (152–182) 173 (158–185) 0.58b
Type of hernia (Rutkow classiWcation)—EHS classiWcation (% and nr of patients)
1 (indirect—normal deepening ring)—L1 3 (3.0%) 18 (18.2%) 0.006c
2 (indirect—dilated ring <4 cm)—L2 45 (45.0%) 35 (35.4%)
3 (indirect—ring >4 cm)—L3 21 (21.0%) 25 (25.3%)
4 (direct—large defect of the canal Xoor) M2 or 3 24 (24.0%) 12 (12.1%)
5 (direct—small medial oriWce)—M1 4 (4.0%) 5 (5.1%)
6 (combined direct and indirect)—L1 M 3 (3.0%) 4 (4.1%)
Pain before operation (days) 3 (0–240) 5 (0–200) 0.013b
Duration of operation (min) 40 (15–125) 35 (20–95) 0.43b
Time from hernia occurrence to operation (days) 6 (0.5–240) 6 (0.5–480) 0.52b
Pain before operation (n, % of population and 95% CI) 67, 67.0% (57.3–75.4) 62, 62.6% (52.8–71.6) 0.52d
Table 2 Peri- and post-operative complications and analgesics intake in both groups. Data are presented as n [% and (CI)], all comparisons cal-
culated with chi-square test or with chi-square test with Yates correction
Assessed value Non-woven WN, (n =1 0 0 ) H W  P P ,  ( n =9 9 ) P value
Perioperative nerve injury 0 [0% (0–3.7)] 1 [1% (0.2–5.45)] 1.0
Analgesics consumption on 1st postoperative day 90 [90% (82.6–94.5)] 91 [95% (84.9–95.9)] 0.64
SuperWcial haematoma 1 [1% (0.2–5.45)] 7 [7.1% (3.5–13.9)] 0.07
Urine retention 0 [0% (0–3.7)] 1 [1% (0.2–5.45)] 1.0
Need for urinary catheter placement 1 [1% (0.2–5.45)] 1 [1% (0.2–5.45)] 1.0
Redness of wound or wound edema 1 [1% (0.2–5.45)] 8 [8.1% (4.2–15.1)] 0.039
Wound infection 0 [0% (0–3.7)] 0 [0% (0–3.7)] 1.0
Recurrence after 12 months 0 [0% (0–3.7)] 0 [0% (0–3.7)] 1.0
Recurrence after 60 months 1 [1% (0.2–5.45)] 3 [3% (1.0–8.50] 0.61
Table 3 Patients suVering for pain in examined groups. Data are
presented as n [% and (CI)]
a Calculated with chi-square test
b Calculated with chi-square test with Yates correction
Visit Non-woven WN, 
(n = 100)
HW PP, (n =9 9 ) P value
Preoperatively 67 [67% (57.3–75.4)] 62 [62.6% (52.8–71.5)] 0.52a
7 days 42 [42% (32.8–51.8)] 55 [55.6% (45.7–64.9)] 0.06a
3 months 16 [16% (10.1–24.4)] 23 [23.2% (16.0–32.5)] 0.19a
6 months 5 [5% (2.2–11.2)] 10 [10.1% (5.6–17.6)] 0.28b
12 months 6 [6% (2.8–12.5)] 8 [8.1% (4.15–15.1)] 0.57a
60 months 2 [2% (0.6–7.0)] 2 [2% (0.6–7.1)] 1.0500 Hernia (2011) 15:495–501
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has been added to the polypropylene Wbres to decrease the
weight of mesh during the incorporation process, and the
potential advantage conferred by partially absorbable light-
weight meshes, such as Vypro, Vypro II and Ultrapro, has
been conWrmed in clinical studies conducted by Post,
O’Dwyer and the Polish Hernia Study Group [5, 6, 8]. The
incidence of pain of any sort was generally two times lower
in lightweight mesh groups, but the values ranged from
39% [5] to 3.8% [8] for the LW meshes, and from 51% to
6.8% in the HW groups, respectively. On the other hand,
Bringman found no signiWcant diVerence in pain scores
when a Vypro II implant was compared with polypropylene
mesh in another large study (only the pain occurring when
rising from a lying to a sitting position was lower in the
lightweight mesh group) [7]. There is no meta-analysis of
the above-mentioned trials, and the values measured seems
to diVer due to the diVerent protocols used for assessment
of pain. In our present study, early postoperative pain
depended on the mesh used. These trends were also noted
over the Wrst 3 months, but the small number of patients
precluded deWnitive statistical evaluation. However, the
incidence of pain observed here was comparable to pain
from lightweight meshes, which may also conWrm the Wnd-
ings of other trials [8, 14]. For other meshes (low weight
partially absorbable meshes), the tissue reaction and Wbro-
blastic ingrowth creates a scar that is responsible for mesh
shrinkage; this has been described in experimental studies
[4]. Formation of an elastic scar on megaporous meshes
should theoretically prevent pain and/or a feeling of a for-
eign body in the groin. These diVerences in pathophysio-
logical processes have not been observed for the WN
implant. Experimental studies have shown no statistical
diVerences in visual sign of inXammatory response
(electron-microscope measurements), Wbrotic reaction and
implant integration for non-woven mesh compared to HW
knitted polypropylene [15]. Only the total amount of mac-
rophages at the site of the mesh was statistically higher in
the non-woven mesh group, which supports the assumption
of a more pronounced inXammatory reaction caused by the
mesh structure [15].
In the last few decades, recurrence has been shown to be
an outcome of less value than pain, due to an incidence
below 1–2% in 3–5 years of follow-up. Introduction of
lightweight meshes has again focussed attention on this
complication. In most studies, the recurrence rate was sig-
niWcantly higher in the lightweight mesh groups, being as
high as 5% [6]. The authors of the O’Dwyer’s trial sug-
gested that the high rate of recurrence may be a conse-
quence of the diVerent elastic properties of Vypro II mesh,
and could require modiWcation of the Wxation technique.
The modiWcation of the operative technique postulated by
O’Dwyer and applied by the Polish Hernia Study Group
has reduced the recurrence rate to accepted levels of about
2% in Wrst year of observation [8, 16]. Although the rate
noted in the present study was less than 2% after 1 year for
the HW implant, it was lower still in the non-woven WN
group. Additionally, the WN mesh described here does not
require any modiWcation of the classical Lichtenstein tech-
nique due to its Wrmness and shape memory. We did not
Wnd any diVerences when handling and suturing this
implant. In this study, as in the pilot study, we did not
observe any recurrences in the WN group up to 1 year, and
very low recurrence rates after 5 years.
Summarizing the described Wndings, we conclude that
the examined lightweight implant shows good results in
preventing postoperative pain, being comparable with other
low weight materials and superior to HW mesh. Also, the
low recurrence rate at 5-year follow-up conWrms the value
of this implant, especially considering that long-term
results have not been described for other LW materials to
date. WN mesh can be safely considered as an appropriate
choice of implant for primary inguinal mesh repair.
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